Literature DB >> 28120637

Successful treatment with tocilizumab for refractory scleritis associated with relapsing polychondritis.

H Shimizu1, H Nishioka1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28120637     DOI： 10.1080/03009742.2016.1275774

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  4 in total

1.  Ocular inflammation associated with relapsing polychondritis in Japanese patients: a review of 11 patients.

Authors:  Rie Tanaka; Toshikatsu Kaburaki; Hisae Nakahara; Keiko Komae
Journal:  Int Ophthalmol       Date:  2019-05-10       Impact factor: 2.031

Review 2.  The Two-Faced Cytokine IL-6 in Host Defense and Diseases.

Authors:  Masashi Narazaki; Tadamitsu Kishimoto
Journal:  Int J Mol Sci       Date:  2018-11-09       Impact factor: 5.923

3.  New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy.

Authors:  Claudia Fabiani; Jurgen Sota; Maite Sainz-de-la-Maza; Laura Pelegrín; Giacomo Emmi; Giuseppe Lopalco; Florenzo Iannone; Lorenzo Vannozzi; Silvana Guerriero; Maria Chiara Gelmi; Donato Rigante; Gian Marco Tosi; José Hernández-Rodríguez; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2020-01-17       Impact factor: 4.711

Review 4.  Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review.

Authors:  Jurgen Sota; Matteo-Maria Girolamo; Bruno Frediani; Gian Marco Tosi; Luca Cantarini; Claudia Fabiani
Journal:  Ophthalmol Ther       Date:  2021-09-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.